id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-D-5585-0001,FDA,FDA-2019-D-5585,Bridging for Drug-Device and Biologic- Device Combination Products; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2019-12-19T05:00:00Z,2019,12,2019-12-19T05:00:00Z,2020-02-19T04:59:59Z,2020-02-21T13:51:04Z,2019-27354,0,0,0900006484235c2e
FDA-2019-D-5585-0002,FDA,FDA-2019-D-5585,Bridging for Drug-Device and Biologic-Device Combination Products Guidance for Industry DRAFT GUIDANCE,Other,Guidance,2019-12-19T05:00:00Z,2019,12,2019-12-19T05:00:00Z,2020-04-21T03:59:59Z,2024-11-12T23:14:38Z,,1,0,090000648423689e